Upstate Active Clinical Trials
Study Title:
AGCT1531 - A Phase 3 Study of Active Surveillance for Low Risk and a Randomized Trial of Carboplatin vs. Cisplatin for Standard Risk Pediatric and Adult Patients with Germ Cell TumorsWhat is the purpose of the study? (in Layman's terms, please describe the study)
A Phase 3 Study of Active Surveillance for Low Risk and a Randomized Trial of Carboplatin vs. Cisplatin for Standard Risk Pediatric and Adult Patients with Germ Cell TumorsUpstate Institutional Review Board (IRB) Number:
1071634Study/Protocol ID:
AGCT1531Study Phase:
IIIPatient Age Group:
Adults and ChildrenPrincipal Investigator:
Melanie A ComitoWho is eligible?
There is no age limit for the Low Risk Stratum (Stage I Ovarian ImmatureTeratoma and Stage I Non-Seminoma or Seminoma Malignant GCT (all
sites))
Standard Risk 1: Patients must be < 11 years of age at enrollment.
Standard Risk 2:Patients must be ≥ 11 and < 25 years of age at enrollment.
What is involved if I participate?
- How long is the study?
N/A - Is transportation provided or reimbursed?
No - Is parking provided or reimbursed?
Yes - What tests and procedures are involved?
N/A
Where will the study take place?
Upstate Pediatric Cancer CenterOther Information:
N/AWho can I contact for more information?
Name: Karen B Bilynsky
Phone: 315-464-7601
Email: [email protected]